Filtered By:
Cancer: Lymphoma
Therapy: Proton Therapy
This page shows you your search results in order of date.
Order by Relevance | Date
Total 30 results found since Jan 2013.
Systematic Review for Deep Inspiration Breath Hold in Proton Therapy for Mediastinal Lymphoma: A PTCOG Lymphoma Subcommittee Report and Recommendations
CONCLUSION: Accounting for heart, lung, breast, and integral dose, proton therapy (FB or DIBH) was superior to IMRT-DIBH. Proton-DIBH can lower dose to the lungs and heart even further compared with proton-FB, depending on disease location in the mediastinum, and organ-sparing and target coverage priorities.PMID:36252635 | DOI:10.1016/j.radonc.2022.10.003
Source: Radiotherapy and Oncology : journal of the European Society for Therapeutic Radiology and Oncology - October 17, 2022 Category: Radiology Authors: Chirayu G Patel Jennifer Peterson Marianne Aznar Yolanda D Tseng Scott Lester Deanna Pafundi Stella Flampouri Pranshu Mohindra Rahul R Parikh Raymond Mailhot Vega Laila Konig John P Plastaras James E Bates Pierre Loap Youlia M Kirova Ester Orlandi Carola Source Type: research
Cardiotoxicity model-based patient selection for Hodgkin lymphoma proton therapy
CONCLUSION: While a statistically significant clinical benefit is theoretically expected for ischemic heart disease, cardiac heart failure and valvular disease for mediastinal HL patients with IMPT, the overall cardiotoxicity risk reduction is notable only for a minority of patients. In the context of limited IMPT availability, this study proposed a general model-based selection approach for mediastinal HL patient based on calculated cardiotoxicity reduction, taking into consideration patient clinical characteristics and IMPT facility availability.PMID:35668710 | DOI:10.1080/0284186X.2022.2084639
Source: Acta Oncologica - June 7, 2022 Category: Cancer & Oncology Authors: Pierre Loap Ester Orlandi Ludovic De Marzi Viviana Vitolo Amelia Barcellini Alberto Iannalfi R émi Dendale Youlia Kirova Alfredo Mirandola Source Type: research
Technical challenges in the treatment of mediastinal lymphomas by proton pencil beam scanning and deep inspiration breath-hold
CONCLUSION: IMPT in DIBH is effective and reproducible to treat mediastinal lymphomas. Caution is recommended to guarantee robust dose delivery to high-risk regions at the interface between lungs and soft tissue.PMID:35189153 | DOI:10.1016/j.radonc.2022.02.015
Source: Radiotherapy and Oncology : journal of the European Society for Therapeutic Radiology and Oncology - February 21, 2022 Category: Radiology Authors: Roberto Righetto Francesco Fracchiolla Lamberto Widesott Stefano Lorentini Francesco Dionisi Barbara Rombi Daniele Scartoni Sabina Vennarini Marco Schwarz Paolo Farace Source Type: research
Vital organ sparing with proton therapy for pediatric hodgkin lymphoma: Toxicity and outcomes in 50 patients
CONCLUSION: For pediatric HL patients, proton treatment resulted in marked dose sparing of OARs with low rates of toxicity, no marginal failures, and excellent 5-year survival.PMID:35101461 | DOI:10.1016/j.radonc.2022.01.016
Source: Radiotherapy and Oncology : journal of the European Society for Therapeutic Radiology and Oncology - February 1, 2022 Category: Radiology Authors: Kathryn R Tringale Leslie A Modlin Kevin Sine Christopher J Forlenza Oren Cahlon Suzanne L Wolden Source Type: research
Guide for paediatric radiotherapy procedures
We present the update of the recommendations of the French society for radiation oncology on the indications, the technical methods of realization and the organisation and the specificities of paediatric radiation oncology.PMID:34969622 | DOI:10.1016/j.canrad.2021.11.018
Source: Cancer Radiotherapie - December 31, 2021 Category: Cancer & Oncology Authors: A Laprie V Bernier L Padovani V Martin C Chargari S Supiot L Claude Source Type: research
